Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen as a Short Candidate
Seeking Alpha
Wednesday, January 13, 2010 - 9:23am
tags:
Amgen
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Wednesday, January 13, 2010 - 9:22am
tags:
Biogen Idec, Tysabri, MS, multiple sclerosis
Glaxo to Seek U.S. Approval for Lupus Drug This Year
Bloomberg
Wednesday, January 13, 2010 - 9:20am
tags:
lupus, GSK, Benlysta
Biomedical Research Funding Is Slowing
Pharmalot
Wednesday, January 13, 2010 - 9:19am
tags:
R&D, funding
Big Pharma, Generic Competition and Cash
WSJ Online
Wednesday, January 13, 2010 - 9:15am
tags:
generics, FTC, Big Pharma
SEC Files Insider Trading Suit Against Drug Exec
Pharmalot
Wednesday, January 13, 2010 - 7:54am
tags:
SEC, Indevus, Endo, insider trading
AstraZeneca, Sanofi, Merck Heart Drugs Cut Alzheimer’s Disease
Bloomberg
Wednesday, January 13, 2010 - 7:53am
tags:
Alzheimer's disease, Merck, Sanofi, AstraZeneca, ARBs
Two Strikes for Gilead's Non-HIV Franchises
BNET Pharma
Tuesday, January 12, 2010 - 9:00pm
tags:
Gilead Sciences, darusentan, Ranexa
[video]Diabetes Setback
Yahoo/CNBC
Tuesday, January 12, 2010 - 8:59pm
tags:
MannKind, inhaled insulin, diabetes
Glaxo Exercises Drug Option
Yahoo/Zacks.com
Tuesday, January 12, 2010 - 8:58pm
tags:
GSK, licensing, Merck, Bristol-Myers Squibb, ChemoCentryx
Competitive Schizophrenia Market
Yahoo/Zacks.com
Tuesday, January 12, 2010 - 8:56pm
tags:
schizophrenia, Eli Lilly, Novartis, Vanda, Zyprexa Relprevv, Fanapt
BDSI eyes $2B market with FDA meeting
Bizjournals.com
Tuesday, January 12, 2010 - 12:49pm
tags:
FDA, BioDelivery Sciences
[video] Stocks Under $10: 2 Hot Biotech Names
TheStreet.com
Tuesday, January 12, 2010 - 12:46pm
tags:
biotech, Spectrum Pharmaceuticals, SciClone
What Did GlaxoSmithKline Get in Return for Buying Sirtris?
Seeking Alpha
Tuesday, January 12, 2010 - 10:35am
tags:
GSK, M&A, Sirtris
Antipsychotic use dropped 19% after warning
Fierce Pharma
Tuesday, January 12, 2010 - 10:24am
tags:
antipsychotics, warnings, Eli Lilly, JNJ, Risperdal, Zyprexa
Notes From JP Morgan: Rochentech
InVivo
Tuesday, January 12, 2010 - 10:09am
tags:
Roche, Genentech, biotech
Novartis leads drug stocks lower
Marketwatch
Tuesday, January 12, 2010 - 10:04am
tags:
Novartis, drug stocks
Exelixis: Volatility Expected to Subside in 2010
Seeking Alpha
Tuesday, January 12, 2010 - 10:01am
tags:
Exelixis
Vical: Collategene gets OK for late-stage trial
Fierce Biotech
Tuesday, January 12, 2010 - 10:00am
tags:
Vical, Collategene, clinical trials
Tocilizumab Approval Causes Buzz
Elsevier Global Medical News
Tuesday, January 12, 2010 - 9:58am
tags:
tocilizumab, Roche, FDA, rheumatoid arthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.